ACHL

Analyst Sentiment

Wall St. Consensus
Hold
5 analysts·Limited coverage
50
Score
2 Buy (40%)1 Hold (20%)2 Sell (40%)
Rating Breakdown
Strong Buy
00%
Buy
240%
Hold
120%
Sell
240%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$2.00
+35.1%
Consensus
$2.00
+35.1%
Bull
$2.00
+35.1%
12-Month Target Range5 analysts
$2.00$2.00$2.00
Current $1.48Consensus
Current Price
$1.48
Upside to Consensus
$0.52

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev
EPS
FY2028
Rev
EPS
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028E
Revenue Avg
Low
High
EBITDA Avg
Low
High
EBIT Avg
Low
High
Net Income Avg$-49M$-57M$-67M
Low$-49M$-57M$-67M
High$-49M$-57M$-67M
EPS Avg$-1.22$-1.43$-1.68
Low$-1.22$-1.43$-1.68
High$-1.22$-1.43$-1.68
Analysts (Rev / EPS) / 1 / 1 / 1

Earnings Surprises

Recent Analyst Actions

Apr 4, 2024Piper Sandler
Piper downgardes Achilles Therapeutics, says 'step-function' change needed
Target:$2.00
+121.5%from $0.90
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.